Exact compound and country check

AOD-9604 in Canada

Health Canada records a seller-labelled 5 mg AOD-9604 product among unauthorized injectable peptide products seized from a Canadian business.

Evidence lane
Health Canada unauthorized product record
Destination
Canada
Source records
3
Reviewed
July 21, 2026
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

What does a search for AOD-9604 in Canada need to establish?

Health Canada records a seller-labelled 5 mg AOD-9604 product among unauthorized injectable peptide products seized from a Canadian business. That finding does not authenticate or determine the status of a different listing, seller, presentation, or supply route.

02

Which official records should be checked for AOD-9604 in Canada?

Resolve the exact identity of AOD-9604 through Read the FDA source from U.S. Food and Drug Administration. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.

03

Does an online listing prove AOD-9604 is authorized or available in Canada?

No. A page using the name AOD-9604, local currency, a domestic delivery claim, or a familiar package image is only a lead. AOD-9604 reached controlled human studies, but the largest oral obesity trial did not show a statistically significant weight-loss difference and the sponsor terminated development for obesity. FDA states that neither AOD-9604 free base nor acetate is a component of an approved drug. Current seller-labelled 5 mg research vials do not inherit the identity, route, formulation, manufacturing record, or monitoring of the historical trial products. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Continue the exact comparison

Related country and compound records.

Compare another tracked name in Canada, or keep AOD-9604 fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

AOD-9604 in North America

AOD-9604 across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Health Canada records a seller-labelled 5 mg AOD-9604 product among unauthorized injectable peptide products seized from a Canadian business. That finding does not authenticate or determine the status of a different listing, seller, presentation, or supply route.

Primary identity source: Read the FDA source / U.S. Food and Drug Administration
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Read the FDA source

Read the FDA source is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Read the FDA source

Drug Product Database

Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug Product Database

Choosing a safe online pharmacy

Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Choosing a safe online pharmacy
Canada / Country guide

Canada market context.

Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.

  • Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
  • The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
  • Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the DIN

Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.

02

Verify the pharmacy

Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.

03

Separate research labels

Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

Audit and handoff

Keep the exact record attached.